EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

calcium levulinate anhydrous
pentanoic acid, 4-oxo-, calcium salt (2:1)

Supplier Sponsors

Name:calcium;4-oxopentanoate
CAS Number: 591-64-0Picture of molecule3D/inchi
ECHA EINECS - REACH Pre-Reg:209-725-9
FDA UNII: LLQ966USIL
Nikkaji Web:J6.758J
MDL:MFCD00045959
Molecular Weight:270.29478000
Formula:C10 H14 Ca O6
NMR Predictor:Predict (works with chrome, Edge or firefox)
Category:information only not used for fragrances or flavors
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Boiling Point: 242.90 °C. @ 760.00 mm Hg (est)
Vapor Pressure:0.010900 mmHg @ 25.00 °C. (est)
Flash Point: 239.00 °F. TCC ( 115.00 °C. ) (est)
logP (o/w): -0.490 (est)
Soluble in:
 water, 1e+006 mg/L @ 25 °C (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
None found
 
Suppliers:
BOC Sciences
For experimental / research use only.
Calcium Levulinate 99%
Santa Cruz Biotechnology
For experimental / research use only.
Levulinic Acid Calcium Salt
TCI AMERICA
For experimental / research use only.
Calcium Levulinate Dihydrate >98.0%(T)
 
Safety Information:
Preferred SDS: View
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
oral-mouse LD50 7250 mg/kg
Farmaco, Edizione Pratica. Vol. 26, Pg. 144, 1971.

oral-rat LD50 6140 mg/kg
Farmaco, Edizione Pratica. Vol. 26, Pg. 144, 1971.

Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
information only not used for fragrances or flavors
Recommendation for calcium levulinate anhydrous usage levels up to:
 not for fragrance use.
 
Recommendation for calcium levulinate anhydrous flavor usage levels up to:
 not for flavor use.
 
Safety References:
EPI System: View
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):591-64-0
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :11578
National Institute of Allergy and Infectious Diseases:Data
calcium;4-oxopentanoate
Chemidplus:0000591640
RTECS:SA4000000 for cas# 591-64-0
 
References:
 calcium;4-oxopentanoate
NIST Chemistry WebBook:Search Inchi
Pubchem (cid):11578
Pubchem (sid):134977275
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
HMDB (The Human Metabolome Database):Search
Export Tariff Code:2918.30.9000
ChemSpider:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 not found in nature
 
Synonyms:
 calcium 4-oxopentanoate
 calcium bis(4-oxovalerate)
 calcium pharmacon
 calcium;4-oxopentanoate
 flanthin
 laevucalcin
 levucal
 levulinic acid, calcium salt
 mil-U-cal
 pentanoic acid, 4-oxo-, calcium salt (2:1)
 

Articles:

PubMed:Calcium-43 chemical shift and electric field gradient tensor interplay: a sensitive probe of structure, polymorphism, and hydration.
PubMed:Metabolomics and mass isotopomer analysis as a strategy for pathway discovery: pyrrolyl and cyclopentenyl derivatives of the pro-drug of abuse, levulinate.
PubMed:Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate.
PubMed:[Lactic acidosis and accumulation of glutamate in the blood of neonates following treatment with calcium levulinate for hypocalcaemia].
PubMed:[Lactic acidosis and accumulation of glutamate in the blood of neonates following treatment with calcium levulinate for hypocalcaemia].
PubMed:Freezing points and small-scale deicing tests for salts of levulinic acid made from grain sorghum.
PubMed:Complex biochemical syndrome of hypocalcemia and hypoparathyroidism during cytotoxic treatment of an infant with leukemia.
PubMed:[Studies of the stability of calciferol and calcium levulinate injection].
PubMed:Calcium-dependent electrical activity and contraction of voltage-clamped frog single muscle fibres.
PubMed:Calcium levulinate medication. A pitfall in the diagnosis of organic acidurias.
PubMed:[Research on calcium pyrrolidinecarboxylate: comparative test with calcium chloride, calcium glutamate, calcium gluconate, calcium lactate and calcium levulinate].
PubMed:[Considerations on calcium & phosphate metabolism, especially after intravenous injection of calcium levulinate].
PubMed:Branuloma cutis calcinosum following injection of calcium levulinate.
 
Notes:
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy